Sign inJoin waitlistJoin the waitlist

Ann LaCasce

Fellowship Program in Hematology/Oncology Chair · Mass General Brigham

Credentials: · · ·

History

Medical Oncology
1999–2001
Internal Medicine
Brigham and Women's Hospital
1996–1999
Tufts University School of Medicine
1992–1996

Research

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Blood · 2022 · 1,363 citations
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
New England Journal of Medicine · 2018 · 972 citations
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Blood · 2014 · 745 citations

Philippe Armand
50 papers
David Fisher
45 papers
Eric Jacobsen
41 papers
JA
Jeremy Abramson
37 papers
Nancy Bartlett
34 papers
AZ
Andrew Zelenetz
33 papers
Caron Jacobsen
32 papers · 1 as a fellow
Jennifer Brown
27 papers
Julie Vose
27 papers
Leo Gordon
27 papers
Jennifer Crombie
26 papers · 5 as a fellow
Ranjana Advani
26 papers

Clinical trials

Cyclophosphamide and Alemtuzumab In Lymphoma
Principal investigator · Terminated · Phase 1
Dana-Farber Cancer Institute
2017–2018
Ph II CHOP+Velcade in Mediastinal LBCL
Principal investigator · Terminated · Phase 2
Dana-Farber Cancer Institute
2006–2008
Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma
Study chair · Completed · Phase 2
Alliance for Clinical Trials in Oncology
2010–2021
Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
Study chair · Completed · Phase 2
Bayer
2003–2009